ATE295183T1 - Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten - Google Patents

Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten

Info

Publication number
ATE295183T1
ATE295183T1 AT99922538T AT99922538T ATE295183T1 AT E295183 T1 ATE295183 T1 AT E295183T1 AT 99922538 T AT99922538 T AT 99922538T AT 99922538 T AT99922538 T AT 99922538T AT E295183 T1 ATE295183 T1 AT E295183T1
Authority
AT
Austria
Prior art keywords
agents
relieving itch
pgd2 antagonists
antagonists
containing pgd2
Prior art date
Application number
AT99922538T
Other languages
English (en)
Inventor
Akinori Arimura
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE295183T1 publication Critical patent/ATE295183T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99922538T 1998-06-03 1999-05-28 Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten ATE295183T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15433298 1998-06-03
PCT/JP1999/002820 WO1999062555A1 (en) 1998-06-03 1999-05-28 Remedies for itching containing pgd2 antagonists

Publications (1)

Publication Number Publication Date
ATE295183T1 true ATE295183T1 (de) 2005-05-15

Family

ID=15581844

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922538T ATE295183T1 (de) 1998-06-03 1999-05-28 Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten

Country Status (11)

Country Link
EP (1) EP1084711B1 (de)
JP (1) JP3857525B2 (de)
KR (1) KR100422920B1 (de)
CN (1) CN1198649C (de)
AT (1) ATE295183T1 (de)
AU (1) AU3955199A (de)
CA (1) CA2333868A1 (de)
DE (1) DE69925270T2 (de)
ES (1) ES2241283T3 (de)
TW (1) TWI239849B (de)
WO (1) WO1999062555A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5430100A (en) 1999-07-02 2001-01-22 Shionogi & Co., Ltd. Novel process for producing bicyclic amino alcohol
US6410583B1 (en) * 2000-07-25 2002-06-25 Merck Frosst Canada & Co. Cyclopentanoindoles, compositions containing such compounds and methods of treatment
US7217725B2 (en) 2000-09-14 2007-05-15 Allergan, Inc. Prostaglandin D2 antagonist
US7273883B2 (en) 2000-09-14 2007-09-25 Allergan, Inc. Prostaglandin EP4 antagonist
US6933317B2 (en) * 2000-11-01 2005-08-23 Shionogi & Co. Ltd. PGD2 receptor antagonistic pharmaceutical compositions
AU2002229611A1 (en) * 2000-12-08 2002-06-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
US20040235955A1 (en) * 2001-09-14 2004-11-25 Masami Narita Remedies for pruritus
AR038136A1 (es) 2002-01-24 2004-12-29 Merck Frosst Canada Inc Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
KR20040083416A (ko) * 2002-02-22 2004-10-01 다이쇼 세이야꾸 가부시끼가이샤 지양제
US7737182B2 (en) 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
JP3678366B2 (ja) 2002-08-09 2005-08-03 大正製薬株式会社 止痒剤
WO2004039807A1 (en) 2002-10-30 2004-05-13 Merck Frosst Canada & Co. Pyridopyrrolizine and pyridoindolizine derivatives
US7714132B2 (en) 2004-03-11 2010-05-11 Actelion Pharmaceuticals, Ltd. Tetrahydropyridoindole derivatives
JPWO2006068162A1 (ja) * 2004-12-24 2008-06-12 塩野義製薬株式会社 慢性閉塞性肺疾患の治療剤
FR2898893A1 (fr) 2006-03-27 2007-09-28 Ppg Sipsy Soc Par Actions Simp Procede d'alkylation diastereoselective d'ether d'oxime du compose nopinone et nouveaux intermediaires pour la synthese de derives 2-amino-nopinone diastereospecifiques substitues sur le carbone 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
CN1134411C (zh) * 1995-06-21 2004-01-14 盐野义制药株式会社 双环氨基衍生物及含有此类化合物的前列腺素d2拮抗剂
PL191760B1 (pl) * 1996-12-13 2006-06-30 Shionogi & Co Związki, pochodne benzotiofenokarboksyamidu, związki pośrednie, kompozycja farmaceutyczna zawierająca te pochodne oraz lek do leczenia blokady nosa

Also Published As

Publication number Publication date
DE69925270D1 (de) 2005-06-16
JP3857525B2 (ja) 2006-12-13
WO1999062555A1 (en) 1999-12-09
KR20010043937A (ko) 2001-05-25
EP1084711A1 (de) 2001-03-21
TWI239849B (en) 2005-09-21
CA2333868A1 (en) 1999-12-09
CN1304320A (zh) 2001-07-18
EP1084711A4 (de) 2003-05-14
ES2241283T3 (es) 2005-10-16
AU3955199A (en) 1999-12-20
DE69925270T2 (de) 2006-02-23
EP1084711B1 (de) 2005-05-11
KR100422920B1 (ko) 2004-03-12
CN1198649C (zh) 2005-04-27

Similar Documents

Publication Publication Date Title
ATE295183T1 (de) Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
NO950297D0 (no) Prolinamidderivater
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
DE68914438D1 (de) N-(3,4-dimethoxycinnamoyl)-Anthranilsäure enthaltende Arzneimittelzusammensetzungen.
ATE272398T1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
BR0108816A (pt) Derivados de quinolina como antagonistas alfa-2
DE69429328D1 (de) N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten
NO20043115L (no) Substituerte diketopiperaziner som oksytocin antagonister
DE60029242D1 (de) Arzneien zur begleitenden behandlung von glaukomen
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
ATE324890T1 (de) Zusammensetzung enthaltend einen angiotensin-ii- rezeptor-antagonist und einen diuretikum und deren verwendung zur behandlung von bluthochdruck
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
DE60028928D1 (de) Verwendung von angiotensin ii rezeptorantagonisten zur behandlung von akutem myokardischen infarkt
EA200601592A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
WO1998031704A3 (en) Tachykinin antagonists
DK0911026T3 (da) Creatinderivater for astma
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
ATE248163T1 (de) Neuartige, pharmazeutisch aktive verbindung
RU95106652A (ru) Оптически активные производные карбоксамида, аналгезирующее средство
EA200401617A1 (ru) Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties